✦ LIBER ✦

42 Results of a one-year international phase IIB trial of LDT, and LDT plus lamivudine, in patients with chronic hepatitis B

✍ Scribed by S.H. Han; N.W.Y. Leung; E.K. Teo; M. Tong; F. Wong; H.W. Hann; T. Poynard; N.A. Brown; M. Myers; G. Chao; D. Lloyd; C.L. Lai

Book ID: 117372872
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 61 KB
Volume: 40
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(04)90042-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

219 Results of a one-year international

219 Results of a one-year international phase IIB comparative trial of telbivudine, lamivudine, and the combination, in patients with chronic hepatitis B

✍ Ching-Lung Lai; Nancy W.Y. Leung; Eng-Kiong Teo; Florence Wong; Hie-Wan Hann; St 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

539 2-YEAR RESULTS OF TELBIVUDINE (LDT)

539 2-YEAR RESULTS OF TELBIVUDINE (LDT) ROADMAP STUDY VERIFY THE OPTIMAL EFFICACY AND SAFETY RESULTS IN HBEAG POSITIVE CHRONIC HEPATITIS B (CHB) PATIENTS

✍ T. Piratvisuth; P. Komolmit; T. Tanwandee; W. Sukeepaisarnjaroen; H.L. Chan; M.G 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Telbivudine versus lamivudine in Chinese

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial

✍ Jinlin Hou; You-Kuan Yin; Daozhen Xu; Deming Tan; Junqi Niu; Xiaqiu Zhou; Yuming 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Chronic hepatitis B and its life-threatening sequelae are highly prevalent in China. There is a need for effective new therapies to suppress hepatitis B virus (HBV) replication and ameliorate liver disease. In this study, we compared the efficacy of telbivudine, a nucleoside analogue, with lamivudin

A 1-Year Trial of Telbivudine, Lamivudin

A 1-Year Trial of Telbivudine, Lamivudine, and the Combination in Patients With Hepatitis B e Antigen—Positive Chronic Hepatitis B

✍ Ching-Lung Lai; Nancy Leung; Eng-Kiong Teo; Myron Tong; Florence Wong; Hie-Won H 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 203 KB

P.109 Efficacy and safety of entecavir a

P.109 Efficacy and safety of entecavir and lamivudine in japanese adult patients with chronic hepatitis B infection: a phase 2 clinical trial

✍ M. Shindo; K. Chayama; J. Toyota; K. Fujiwara; J. Sugihara; N. Hayashi; T. Seriu 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 283 KB

781 A CLINICAL TRIAL ON ANTI-HBV-DC VACC

781 A CLINICAL TRIAL ON ANTI-HBV-DC VACCINE COMBINED WITH LAMIVUDINE AND THYMOSIN-a1 IN THE HBeAg POSITIVE PATIENTS OF CHRONIC HEPATITIS B VIRUS INFECTION

✍ Wu, B.-F.; Yang, J.-Y.; Zhang, Y.-L.; Liu, Y.; Zhou, H.-H.; Wang, X.-Q.; Li, F.- 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 67 KB